Evidence map›Paper›PMID 22942178›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2012

Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing.

Catalin F Baicu, Jiayu Li, Yuhua Zhang, Harinath Kasiganesan, George Cooper, Michael R Zile, Amy D Bradshaw

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Molecular Mechanisms of Cardiac Adaptation After Device Deployment.Journal of cardiovascular development and disease · 2025
    Review
  4. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  5. Review
  6. Article
  7. More than just a small left ventricle: the right ventricular fibroblast and ECM in health and disease.American journal of physiology. Heart and circulatory physiology · 2023
    Review
  8. Article
  9. Review
  10. The Role of Matrix Proteins in Cardiac Pathology.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. The Role of Regulatory T Cells in Pulmonary Arterial Hypertension.Journal of the American Heart Association · 2019
    Review
  16. Article
  17. Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis.American journal of physiology. Heart and circulatory physiology · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Catalin F BaicuGazes Cardiac Research Institute, Division of Cardiology, Department of Medicine, Medical University of South Carolina, USA.
Jiayu Li
Yuhua Zhang
Harinath Kasiganesan
George Cooper
Michael R Zile
Amy D Bradshaw
Ralph H. Johnson VA Medical Center · USMedical University of South Carolina · US

Funding

TRANSLATIONAL REGULATION OF CARDIAC PROTEIN SYNTHESISP01HL048788 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI COOPER, GEORGE · 1993 to 2007
$15.9M
Post-Synthetic Procollagen Processing in Load-Induced Left Ventricular RemodelingR01HL094517 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADSHAW, AMY D · 2009 to 2010
$738k
NHLBI NIH HHS P01-HL-48788NHLBI NIH HHS R01-HL-094517
6 · The paper itself

Abstract

Myocardial fibrillar collagen is considered an important determinant of increased ventricular stiffness in pressure-overload (PO)-induced cardiac hypertrophy. Chronic PO was created in feline right ventricles (RV) by pulmonary artery banding (PAB) to define the time course of changes in fibrillar collagen content after PO using a nonrodent model and to determine whether this time course was dependent on changes in fibroblast function. Total, soluble, and insoluble collagen (hydroxyproline), collagen volume fraction (CVF), and RV end-diastolic pressure were assessed 2 days and 1, 2, 4, and 10 wk following PAB. Fibroblast function was assessed by quantitating the product of postsynthetic processing, insoluble collagen, and levels of SPARC (secreted protein acidic and rich in cysteine), a protein that affects procollagen processing. RV hypertrophic growth was complete 2 wk after PAB. Changes in RV collagen content did not follow the same time course. Two weeks after PAB, there were elevations in total collagen (control RV: 8.84 ± 1.03 mg/g vs. 2-wk PAB: 11.50 ± 0.78 mg/g); however, increased insoluble fibrillar collagen, as measured by CVF, was not detected until 4 wk after PAB (control RV CVF: 1.39 ± 0.25% vs. 4-wk PAB: 4.18 ± 0.87%). RV end-diastolic pressure was unchanged at 2 wk, but increased until 4 wk after PAB. RV fibroblasts isolated after 2-wk PAB had no changes in either insoluble collagen or SPARC expression; however, increases in insoluble collagen and in levels of SPARC were detected in RV fibroblasts from 4-wk PAB. Therefore, the time course of PO-induced RV hypertrophy differs significantly from myocardial fibrosis and diastolic dysfunction. These temporal differences appear dependent on changes in fibroblast function.

Indexed as

AnimalsBlood PressureCatsCells, CulturedCollagenDisease Models, AnimalFibroblastsFibrosisHypertrophy, Right VentricularMaleMyocardiumOsteonectinProcollagenTime FactorsVentricular Dysfunction, RightCollagenOsteonectinProcollagen

Identifiers

PMID22942178
PMCPMC3517645
OpenAlexW2072085629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.